‌
  • Sponsored by AbbVie. AbbVie has no influence in the design and content.
  • Supported via arm's length funding from MSD
Highlights from

American College of Rheumatology

annual meeting 2018

Chicago, Illinois 19-24 October 2018
SCROLL TO ARTICLES

    Articles

    Investigational treatments for rheumatic disease

    video

    Upadacitinib shows clinically significant difference in response rate versus adalimumab in active RA

    Tocilizumab for the treatment of systemic sclerosis: efficacy and safety results from phase III trial focuSSced

    Intra-articular TPX-100 for knee tibiofemoral osteoarthritis: recent data from TPX-100-1

    Complete renal response reached earlier with abatacept versus placebo in lupus nephritis

    Long-term data and substudies

    Efficacy and safety profile outcomes of switching from adalimumab to baricitinib: long-term data in patients with rheumatoid arthritis

    Faster decline in maternal mortality in SLE patients as compared with non-SLE patients

    video

    Did changes in composite indices of disease activity correlate with radiographic progression in the GO-VIBRANT trial of active PsA?

    video

    3-year data on secukinumab in ankylosing spondylitis support efficacy and safety profile

    Diagnosis and management

    video

    Diagnosis of giant-cell arteritis more accurate with PET/CT scan than temporal artery biopsy

    Approximately half of RA patients do not have their therapy changed as needed within a year

    Top image: © stockdevil

    The content and interpretation of these conference highlights are the views and comments of the speakers / authors.

    Supported by